Oliver Luxxe Assets LLC Astrazeneca PLC Transaction History
Oliver Luxxe Assets LLC
- $585 Million
- Q4 2025
A detailed history of Oliver Luxxe Assets LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 91,468 shares of AZN stock, worth $8.18 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
91,468
Previous 91,651
0.2%
Holding current value
$8.18 Million
Previous $7.03 Million
16.3%
% of portfolio
1.4%
Previous 1.19%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...